Antimicrobial-associated risk factors for Clostridium difficile infection

Clinical Infectious Diseases

Volumn 46, Issue SUPPL. 1, 2008, Pages

  Owens Jr , Robert C ^a,b   Donskey, Curtis J ^c   Gaynes, Robert P ^d,e   Loo, Vivian G ^f   Muto, Carlene A ^g  

^a MAINE MEDICAL CENTER   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DORIPENEM; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NITAZOXANIDE; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAMOPLANIN; RIFALAZIL; RIFAXIMIN; TIACUMICIN B; TIGECYCLINE; TINIDAZOLE; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE; COLON FLORA; EPIDEMIC; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ADULT; DISEASE MANAGEMENT; DRUG COMBINATION; DRUG EFFECT; ECOSYSTEM; GROWTH, DEVELOPMENT AND AGING; INTESTINE; MICROBIOLOGY; PATHOGENICITY; PSEUDOMEMBRANOUS COLITIS; TIME;

ADULT; ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; DISEASE MANAGEMENT; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ECOSYSTEM; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INTESTINES; RISK FACTORS; TIME FACTORS;

EID: 39749120072     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/521859     Document Type: Review

References (79)